StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Medivation, Inc.

Enter Symbol or Keywords

OPS Ranking of "4" Reiteration for Medivation

Stock Quote: (NGM:MDVN)

11/09/2009

73.93

+3.67

+5.22%

1,629,291

OPS Ranking of "4" Reiteration for Medivation

Last

Price Change

% Chg

Volume

Sarasota, FL, November 9, 2009-StockDiagnostics.com announced that it has reiterated its OPS Ranking of "4" for Medivation, Inc. (NASDAQ:MDVN). Medivation has had an OPS Ranking of "4" for four conse ... read full story

Website Address:	www.medivation.net
Industry:	Bio-Pharma & Therapeutics

Most Recent STN Exclusives

11/04/2010

Cash Flow from Operations for SAP AG Reaches Nine Year High

11/04/2010

Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com

11/04/2010

Cash Flow from Operations for Pepco Holdings Reaches Four Year High

11/04/2010

Cash Flow from Operations Increases 151% for KLA-Tencor

11/04/2010

Seven Year High in Cash Flow from Operations for Dana Holding

11/04/2010

Public Service Enterprise's Cash Flow from Operations Increases 48%

11/04/2010

StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"

11/04/2010

Free Cash Flow Turns Negative for Goodyear's Third Quarter

11/04/2010

Cash Flow from Operations for Waste Management Increases 17.7%

11/04/2010

Free Cash Flow for America Movil Reaches Three Year High

Interactive Chart: MDVN

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: MDVN

08/17/2010

Three Year High in EBITDA for Medivation

08/16/2010

Revenue for Medivation Increases by 50.47% even though Revenue for Pharmaceuticals Industry Decreases by 1.28% over Latest 12 Months

08/13/2010

StockDiagnostics.com Reiterates Medivation's OPS Ranking of "7"

... more MDVN exclusives

Other News Sources: MDVN

02/02/2012

MDVN: Jumps +1.75%; Vol +54%; Last 90 Min of Trading

02/01/2012

Knobias Sector Commentary

01/31/2012

Medivation and Astellas Announce Positive Results From the Phase 3 AFFIRM Trial of MDV3100 in Prostate Cancer Patients Who Received Prior Chemotherapy

... more MDVN news from other sources

Daily Market Updates

02/03/2012

Markets Rally Today Following Strong January Jobs Report

U.S. markets rallied today following the release of a positive January employment report. The Nasdaq Composite hit at an 11-year high and the Dow closed at its highest level in 3 1/2 years after the report showed that the U.S. economy added 243,000 n ... read full story